Aminophenols
Medchemexpress LLC Imiloxan hydrochloride | 81167-22-8 | 98.5% | 280.75 g/mol | C14H17ClN2O2 | 50 MG
Imiloxan hydrochloride is a research chemical that acts as a selective α2B-adrenoceptor antagonist, supplied as a solid and characterized for laboratory pharmacology studies. It is used to probe adrenergic receptor subtype function in vitro and in vivo, and is accompanied by analytical and safety documentation for research use only.
- Selective α2B-adrenoceptor antagonist for receptor subtype studies.
- High purity suitable for in vitro and in vivo experiments.
- Available in small milligram pack sizes for flexible dosing and formulation.
- Supplied with a product data sheet and safety data sheet for laboratory handling.
- Solid form enables precise weighing and preparation of solutions.
![eMolecules 86347-15-1 | Medetomidine Hydrochloride | Key Organics/BIONET236.740 | C13H17ClN2 | 99.000 | Cl.CC(c1cnc[nH]1)c1cccc(C)c1C | 5mg | 564356414](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000128176.jpg-250.jpg)
eMolecules 86347-15-1 | Medetomidine Hydrochloride | Key Organics/BIONET236.740 | C13H17ClN2 | 99.000 | Cl.CC(c1cnc[nH]1)c1cccc(C)c1C | 5mg | 564356414
Medetomidine Hydrochloride | Key Organics/BIONET | 86347-15-1236.740 | C13H17ClN2 | 99.000 | Cl.CC(c1cnc[nH]1)c1cccc(C)c1C | 5mg | 564356414
Medchemexpress LLC SKI-I 25mg | 306301-68-8 | 25 MG
SKI-I is a research-grade small-molecule inhibitor of sphingosine kinase used in biochemical and cell-based assays to study sphingolipid signaling and apoptosis. Not for human use.
- Potent sphingosine kinase inhibitor (IC50 1.2 μM for ST-hSK).
- Also inhibits hERK2 (IC50 11 μM).
- Induces apoptosis in multiple tumor cell lines.
- High purity (99.14%).
- Soluble in DMSO at 100 mg/mL for in vitro applications.
Medchemexpress LLC Biotin-4-aminophenol | 901770-40-9 | 99.45% | C16H21N3O3S | 100 MG
Biotin-4-aminophenol is a biotin-phenol analog that generates free radicals. It conjugates to tyrosine residues in proteins more efficiently and selectively than the previously reported BP1.
- Biotin-phenol analog
- Generates free radicals
- Efficiently conjugates to tyrosine residues in proteins
- More selective than BP1
- Molecular weight: 335.42
- Appearance: Solid
- Color: White to off-white
Medchemexpress LLC L-NAME (hydrochloride) | 51298-62-5 | 99.89% | 269.69 | 1 G
L-NAME hydrochloride inhibits NOS with an IC50 of 70 μM. L-NAME is a precursor to the NOS inhibitor L-NOARG, which has an IC50 value of 1.4 μM. This product can also be utilized to induce hypertension and preeclampsia models.
- Inhibits NOS with an IC50 of 70 μM.
- Functions as a precursor to the NOS inhibitor L-NOARG, which has an IC50 of 1.4 μM.
- Applicable for inducing hypertension models.
- Applicable for inducing preeclampsia models.
eMolecules 263717-53-9 | Medchem Express | Propyl pyrazole triol | 5mg | 475641433 | HY-100689 | MFCD03453628 | 386.451 | C24H22N2O3
Ambeed | 1245-Tetrabromobenzene | 1g | 642080428 | A248034 | 636-28-2 | MFCD00000063 | 393.698 | C6H2Br4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC NS-3-008 hydrochloride | 1172854-54-4 | 99.7% | 1 ML
NS-3-008 hydrochloride is a small-molecule transcriptional inhibitor of G0/G1 switch 2 (G0s2) with a reported IC50 of 2.25 μM. It is supplied as a concentrate solution for research use and as solids for analytical or in vivo studies. Typical applications include biochemical assays and disease-model investigations such as chronic kidney disease research.
- Transcriptional inhibitor of G0s2 with IC50 ≈ 2.25 μM.
- Available as 10 mM solution in DMSO (1 mL) and as solid packs for flexibility in workflows.
- High purity (99.7%) suitable for biochemical, cellular, and in vivo studies.
- Off-white to light yellow solid with molecular formula C14H24ClN3 and MW 269.81 g·mol⁻¹.
- Supplied with characterization data to support reproducibility in research.
Medchemexpress LLC ZK824190 hydrochloride | 2629177-12-2 | 99.2% | 450.86 g/mol | C22H21ClF2N2O4 | 10MM 1ML
ZK824190 hydrochloride is the hydrochloride salt of a selective, orally available urokinase plasminogen activator (uPA) inhibitor used in research into uPA biology and potential therapies for multiple sclerosis. It is supplied as a high-purity solid and as a pre-made 10 mM solution in DMSO for in vitro and preclinical studies; not for human use.
- Selective urokinase plasminogen activator (uPA) inhibitor.
- Supplied as 10 mM solution in DMSO and as solid quantities.
- High purity suitable for research applications.
- Molecular formula: C22H21ClF2N2O4.
- Molecular weight: 450.86 g/mol.
- CAS: 2629177-12-2 for substance identification.
- Provided as the hydrochloride salt for stability and handling.
- Intended for in vitro and preclinical research only, not for human use.
Medchemexpress LLC Ozagrel (hydrochloride) | 78712-43-3 | MFCD00911569 | 99.9% | 1 ML
Ozagrel hydrochloride is a highly selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. It achieves anti-platelet aggregation, vasodilation, and anti-inflammatory effects by inhibiting TXA2 production and increasing prostacyclin (PGI2) production. This compound is used for the study of ischemic stroke, asthma, and thromboembolic diseases.
- IC50 of 11 nM for TXA2/TP.
- Significantly inhibits platelet aggregation (IC50 53.12 μM) induced by arachidonic acid.
- Improves endothelial dysfunction, oxidative stress, and neuroinflammation in rat models.
- Attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression.
- Documentation includes data sheet, COA, SDS, and handling instructions.
Medchemexpress LLC Daurk-4 hydrochloride | 99.4% | 1071.93 | 50 MG
dAURK-4 hydrochloride is a potent and selective PROTAC AURKA (Aurora A) degrader, derived from Alisertib. This compound exhibits anticancer effects by targeting specific proteins involved in cell proliferation. It is composed of a ligand for the target protein, a linker, and a ligand for the E3 ligase Thalidomide-O-COOH, enabling dose-dependent degradation of AURKA in vitro.
- Potent and selective PROTAC AURKA degrader
- Derivative of Alisertib
- Exhibits anticancer effects
- Composed of specific ligands and a linker for targeted degradation
- Demonstrates dose-dependent degradation of AURKA in vitro
- High purity (99.44%)
Medchemexpress LLC 4-[(S)-amino(carboxy)methyl]-3-methylbenzoic acid hydrochloride | 2829282-00-8 | MFCD02262124 | 99.4% | 245.66 g/mol | C10H12ClNO4 | 1 ML
LY367385 hydrochloride is a selective mGluR1a antagonist supplied as a hydrochloride salt for research use. It is available as a solid and as a ready-to-use 10 mM solution in DMSO (1 mL vial), suitable for in vitro pharmacology and biochemical assays.
- High purity (99.4%) for reproducible assay results.
- Available as 10 mM solution in DMSO for convenient dosing.
- Also supplied as solid for custom formulation and storage.
- Molecular weight 245.66 g/mol and formula C10H12ClNO4.
- CAS number 2829282-00-8 for unambiguous substance identification.
Medchemexpress LLC A 85380 hydrochloride | 174740-86-4 | ≥97.0% | 237.13 | 50 MG
A 85380 hydrochloride is a novel, high affinity neuronal nicotinic acetylcholine receptor (nAChR) agonist. It exhibits selectivity for the α4β2 nAChR subtypes and has a broad-spectrum analgesic profile.
- Novel, high affinity neuronal nicotinic acetylcholine receptor (nAChR) agonist.
- Selectivity for the α4β2 nAChR subtypes.
- Broad-spectrum analgesic profile.
- For research use only.
Medchemexpress LLC Nefopam (hydrochloride) | 23327-57-3 | 99.9% | 100 MG
Nefopam hydrochloride is a centrally-acting, non-opioid, and non-steroidal analgesic drug. It is derived from benzoxazocine and is used for the relief of moderate to severe pain. It targets β-catenin protein levels in mesenchymal cells both in-vitro and in-vivo, inhibiting β-catenin mediated signaling during skin wound repair.
- Centrally-acting analgesic
- Non-opioid and non-steroidal properties
- Aids in the relief of moderate to severe pain
- Inhibits β-catenin mediated signaling
- Derived from benzoxazocine
Medchemexpress LLC Metixene hydrochloride hydrate | 7081-40-5 | 99.9% | 25 MG
Metixene hydrochloride hydrate is an anticholinergic, antiparkinsonian research standard used as a muscarinic acetylcholine receptor antagonist in pharmacology and neuroscience studies. It is supplied as the hydrochloride hydrate salt for improved stability and solubility and is typically provided in small quantities for laboratory research.
- Acts as a muscarinic acetylcholine receptor (mAChR) antagonist for receptor binding and functional assays.
- High purity suitable for analytical and biochemical applications (≈99.9%).
- Molecular weight 363.94 g/mol and formula C20H26ClNOS.
- Available in small package sizes such as 25 MG for laboratory use.
- Provided as a hydrochloride hydrate salt to aid solubility in common solvents.
Medchemexpress LLC (R)-2-hydroxy-3-(tetradecanoyl-d7-oxy)propyl (2-(trimethylammonio)ethyl) phosphate | 00-00-0 | 95.4% | 474.62 | C22H39D7NO7P | 5 MG
LysoPC(14:0/0:0)-d7 is a deuterium-labeled lysophosphatidylcholine used as an isotope-labeled endogenous metabolite standard for analytical and quantitative lipidomics studies. It is provided as a white to off-white solid and is intended for use as an internal standard in mass spectrometry workflows.
- Deuterium-labeled lyso-phosphatidylcholine for isotope-dilution assays.
- Molecular formula C22H39D7NO7P and molecular weight 474.62.
- Purity 95.4% by HPLC as reported on the certificate of analysis.
- Appearance white to off-white solid suitable for analytical use.
- Storage: powder -20°C up to 3 years, 4°C up to 2 years; in solvent -80°C up to 6 months.
- Intended for use as an endogenous metabolite/internal standard in lipidomics and quantitative assays.